Objectives: The recommendations cover indications for MRI examination including acquisition planes, patient preparation, imaging protocol including multi-parametric approaches such as diffusion-weighted imaging (DWI-MR), dynamic contrast-enhanced imaging (DCE-MR) and standardised reporting. The document also underscores the value of whole-body 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) and highlights potential future methods. Methods: In 2019, the ESUR female pelvic imaging working group reviewed the revised 2018 FIGO staging system, the up-to-date clinical management guidelines, and the recent imaging literature. The RAND-UCLA Appropriateness Method (RAM) was followed to develop the current ESUR consensus guidelines following methodological steps: literature research, questionnaire developments, panel selection, survey, data extraction and analysis. Results: The updated ESUR guidelines are recommendations based on ≥ 80% consensus among experts. If ≥ 80% agreement was not reached, the action was indicated as optional. Conclusions: The present ESUR guidelines focus on the main role of MRI in the initial staging, response monitoring and evaluation of disease recurrence. Whole-body FDG-PET plays an important role in the detection of lymph nodes (LNs) and distant metastases. Key points: • T2WI and DWI-MR are now recommended for initial staging, monitoring of response and evaluation of recurrence. • DCE-MR is optional; its primary role remains in the research setting. • T2WI, DWI-MRI and whole-body FDG-PET/CT enable comprehensive assessment of treatment response and recurrence

Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018 / Manganaro, Lucia; Lakhman, Yulia; Bharwani, Nishat; Gui, Benedetta; Gigli, Silvia; Vinci, Valeria; Rizzo, Stefania; Kido, Aki; Margarida Cunha, Teresa; Sala, Evis; Rockall, Andrea; Forstner, Rosemarie; Nougaret, Stephanie. - In: EUROPEAN RADIOLOGY. - ISSN 0938-7994. - 31:10(2021), pp. 7802-7816. [10.1007/s00330-020-07632-9]

Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018

Lucia Manganaro
Primo
;
Silvia Gigli;
2021

Abstract

Objectives: The recommendations cover indications for MRI examination including acquisition planes, patient preparation, imaging protocol including multi-parametric approaches such as diffusion-weighted imaging (DWI-MR), dynamic contrast-enhanced imaging (DCE-MR) and standardised reporting. The document also underscores the value of whole-body 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) and highlights potential future methods. Methods: In 2019, the ESUR female pelvic imaging working group reviewed the revised 2018 FIGO staging system, the up-to-date clinical management guidelines, and the recent imaging literature. The RAND-UCLA Appropriateness Method (RAM) was followed to develop the current ESUR consensus guidelines following methodological steps: literature research, questionnaire developments, panel selection, survey, data extraction and analysis. Results: The updated ESUR guidelines are recommendations based on ≥ 80% consensus among experts. If ≥ 80% agreement was not reached, the action was indicated as optional. Conclusions: The present ESUR guidelines focus on the main role of MRI in the initial staging, response monitoring and evaluation of disease recurrence. Whole-body FDG-PET plays an important role in the detection of lymph nodes (LNs) and distant metastases. Key points: • T2WI and DWI-MR are now recommended for initial staging, monitoring of response and evaluation of recurrence. • DCE-MR is optional; its primary role remains in the research setting. • T2WI, DWI-MRI and whole-body FDG-PET/CT enable comprehensive assessment of treatment response and recurrence
2021
diffusion weighted imaging; magnetic resonance imaging; neoplasm recurrence; neoplasm staging; uterine cervical neoplasms
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018 / Manganaro, Lucia; Lakhman, Yulia; Bharwani, Nishat; Gui, Benedetta; Gigli, Silvia; Vinci, Valeria; Rizzo, Stefania; Kido, Aki; Margarida Cunha, Teresa; Sala, Evis; Rockall, Andrea; Forstner, Rosemarie; Nougaret, Stephanie. - In: EUROPEAN RADIOLOGY. - ISSN 0938-7994. - 31:10(2021), pp. 7802-7816. [10.1007/s00330-020-07632-9]
File allegati a questo prodotto
File Dimensione Formato  
Manganaro_Staging recurrence_2021.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 4.18 MB
Formato Adobe PDF
4.18 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1676965
Citazioni
  • ???jsp.display-item.citation.pmc??? 43
  • Scopus 90
  • ???jsp.display-item.citation.isi??? 79
social impact